vitro diagnostics inc (VODG:OTC US)
vitro diagnostics inc (VODG) Snapshot
|
Open
$0.05
|
Previous Close
$0.05
|
|
|
Day High
$0.06
|
Day Low
$0.05
|
|
|
52 Week High
02/25/13 - $0.15
|
52 Week Low
12/7/12 - $0.02
|
|
|
Market Cap
1.2M
|
Average Volume 10 Days
9.2K
|
|
|
EPS TTM
--
|
Shares Outstanding
19.3M
|
|
|
EX-Date
04/24/89
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
vitro diagnostics inc (VODG) Related Businessweek News
No Related Businessweek News Foundvitro diagnostics inc (VODG) Details
Vitro Diagnostics, Inc., doing business as Vitro Biopharma, focuses on the development, manufacture, and distribution of stem cell products and related tools for use in research and drug discovery. Its stem cell technology includes cell lines, supporting products, and methods for generation and differentiation of stem cells into products with applications to treatment of various diseases, such as heart disease, stroke, Parkinson’s, and Alzheimer’s diseases. The company also develops and sells ‘Tools for Stem Cell and Drug Development’ that offers researchers basic tools needed to advance stem cell technology, including stem cells and their derivatives, media for growth and differentiation of stem cells, and tools for measurement of stem cell quality, potency, and response to toxic agents. In addition, it offers VITROPIN, a purified urinary follicle-stimulating hormone (FSH) preparation; and Cell Line-Derived FSH for immortalization of pituitary cells known as gonadotropes that synthesize and secrete FSH and LH. Further, the company provides fluorescent labeled stem cells, using various specific labels to enhance utility for various applications in stem cell research. It has a strategic alliance with HemoGenix, Inc. to develop products for the determination of stem cell quality, potency, and response to toxic agents. Vitro Diagnostics, Inc. was founded in 1986 and is based in Golden, Colorado.
vitro diagnostics inc (VODG) Top Compensated Officers
vitro diagnostics inc (VODG) Key Developments
On 03/18/2013, Vitro Diagnostics, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Vitro Diagnostics, Inc. accepted the resignation of Mr. Erik Van Horn from its Board of Directors and appointed Pete Shuster, the CEO of Neuromics, Inc. to its Board of Directors. Mr. Shuster is a seasoned and experienced sales executive. He is the current owner of Neuromics, Inc.
Vitro Diagnostics, Inc. filed its 10-K on Feb 12, 2013 for the period ending Oct 31, 2012. In this report its auditor, Schumacher & Associates, Inc, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
| Recently Viewed | |||
| VODG:US | $0.06 USD | +0.01 | |
| Company | Last | Change |
| Life Technologies Corp | $74.10 USD | +0.42 |
| Lonza Group AG | SFr.74.90 CHF | +0.80 |
| View Industry Companies | ||
Industry Analysis
VODG
Industry Average
| Valuation | VODG | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 25.0x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 8.2x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact VITRO DIAGNOSTICS INC, please visit www.vitrobiopharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








